以下部分引用 AI 总结，现阶段 AI 仍然有幻觉。请以内容的原文为准。
数据新鲜度群聊 07-14 ✓卖方 07-14 ✓Wrap 断档15天 ✕News 07-15 ✓X 断档12天 ✕页面生成 07-15
Retatrutide
17 atoms · 跨 6 天 · 首见 2026-04-05 · 最近 2026-06-14
三色: 🟦 fact 14 · 🟥 take 3 · stance ▲3/▼2/◆3
来源: X 17
时态: fresh:17
标签: 好数字:9 · 好观点:5 · 好信源:3
叙事 (narrative) (2)
- 2026-05-22 · Retardatide sounds amazing
Retardatide sounds amazing. Side effects may include … ? 🤷♂️
tags: 好观点 · → daily
- 2026-05-22 · Phase 3 trial outcome
Retatrutide stuns in Phase 3 trials.
tags: 好观点 · → daily
预测 (forecast) (1)
- 2026-05-21 · will completely overshadow tirzepatide and semaglutide, and take the throne as the best-selling drug of all time
Retatrutide is going to completely overshadow tirzepatide and semaglutide, and take the throne as the best-selling drug of all time.
tags: 好观点 · → daily
事实 (fact) (14)
- 2026-06-14 · FDA 批准状态
Retatrutide hasn't yet received FDA approval.
tags: 好信源 · → daily
value: date=2026-06-14
- 2026-06-12 · FDA 批准状态
Retatrutide hasn't yet received FDA approval
tags: 好信源 · → daily
value: date=未获批
- 2026-06-13 · FDA 批准状态
Retatrutide hasn't yet received FDA approval
tags: 好信源 · → daily
- 2026-05-21 · phase 3 obesity trial results: 28.3% bodyweight lost on 12mg over 80 weeks
28.3% bodyweight lost on 12mg over 80 weeks
tags: 好数字 · → daily
value: qty=28.3% · date=80 weeks
- 2026-05-21 · phase 3 obesity trial results: 70.3 pounds on avg. or 31.9 kg
70.3 pounds on avg. or 31.9 kg
tags: 好数字 · → daily
value: qty=70.3 pounds · date=80 weeks
- 2026-05-21 · phase 3 obesity trial results: 45.3% of patients hit 30%+ weight loss
45.3% of patients hit 30%+ weight loss (this is bariatric surgery territory)
tags: 好数字 · → daily
value: qty=45.3%
- 2026-05-21 · phase 3 obesity trial results: 30.3% weight loss (85 lbs) at 104 weeks in higher-BMI patients
30.3% weight loss (85 lbs) at 104 weeks in higher-BMI patients
tags: 好数字 · → daily
value: qty=30.3% · date=104 weeks
- 2026-05-21 · phase 3 obesity trial results: 65.3% of 12mg patients dropped below the obesity BMI threshold
65.3% of 12mg patients dropped below the obesity BMI threshold
tags: 好数字 · → daily
value: qty=65.3%
- 2026-05-21 · phase 3 obesity trial results: 19% loss on 4mg over 80 weeks (47.2 lbs) with fewer dropouts than placebo
19% loss on 4mg over 80 weeks (47.2 lbs) with fewer dropouts than placebo (4.1% vs 4.9%)
tags: 好数字 · → daily
value: qty=19% · date=80 weeks
- 2026-05-21 · phase 3 obesity trial results: significant drops in blood pressure, triglycerides, non-HDL cholesterol, waist circumference, and hsCRP
significant drops in blood pressure, triglycerides, non-HDL cholesterol, waist circumference, and hsCRP
tags: 好数字 · → daily
- 2026-05-21 · phase 3 obesity trial results: no cardiac or liver signals
no cardiac or liver signals
tags: 好数字 · → daily
- 2026-04-05 · 月治疗费用
Retatrutide: $10.91/mo (at 4mg/wk)
tags: 好数字 · → daily
value: qty=$10.91 · unit=/mo (at 4mg/wk)
- 2026-05-21 · 4 to 12mg comes with side effects: Random Paranoia and Anxiety episodes, Sleep disruption, Heart palpitations
For those reading this - 4 to 12mg comes with a lot of side effects that people aren’t discussing. Speaking from first hand experience - Random Paranoia and Anxiety episodes - Sleep disruption - Heart palpitations
tags: 好观点 · → daily
- 2026-05-21 · side effect: I sleep less now and i can feel my heart pounding sometimes when i'm doing nothing
it's true, I sleep less now and i can feel my heart pounding sometimes when i'm doing nothing sort of annoying
tags: 好观点 · → daily
时间轴 (近 20)
- 2026-06-14 ·
fact · FDA 批准状态 · → daily
- 2026-06-13 ·
fact · FDA 批准状态 · → daily
- 2026-06-12 ·
fact · FDA 批准状态 · → daily
- 2026-05-22 ·
narrative · Retardatide sounds amazing · → daily
- 2026-05-22 ·
narrative · Phase 3 trial outcome · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: 28.3% bodyweight lost on 12mg · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: 70.3 pounds on avg. or 31.9 k · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: 45.3% of patients hit 30%+ we · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: 30.3% weight loss (85 lbs) at · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: 65.3% of 12mg patients droppe · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: 19% loss on 4mg over 80 weeks · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: significant drops in blood pr · → daily
- 2026-05-21 ·
fact · phase 3 obesity trial results: no cardiac or liver signals · → daily
- 2026-05-21 ·
forecast · will completely overshadow tirzepatide and semaglutide, and · → daily
- 2026-05-21 ·
fact · 4 to 12mg comes with side effects: Random Paranoia and Anxie · → daily
- 2026-05-21 ·
fact · side effect: I sleep less now and i can feel my heart poundi · → daily
- 2026-04-05 ·
fact · 月治疗费用 · → daily
← 实体目录 · 系统日志